OA11.01 Prolonged OS of Patients Exposed to Weekly Paclitaxel and Bevacizumab: Impact of the Cross-Over in the IFCT-1103 ULTIMATE Study
JOURNAL OF THORACIC ONCOLOGY(2017)
关键词
paclitaxel,Second-line,non-small cell lung cancer (NSCLC),bevacizumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要